These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4571525)

  • 21. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD
    Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboses in myocardial infarction. Comparison in heparin dosage.
    Habersberger PG; Pitt A; Anderson ST
    Br Heart J; 1973 May; 35(5):538-42. PubMed ID: 4716014
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 125I fibrinogen and the prevention of venous thrombosis.
    Hume M; Kuriakose TX; Zuch L; Turner RH
    Arch Surg; 1973 Nov; 107(5):803-6. PubMed ID: 4744294
    [No Abstract]   [Full Text] [Related]  

  • 25. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
    Hull R; Hirsh J; Jay R; Carter C; England C; Gent M; Turpie AG; McLoughlin D; Dodd P; Thomas M; Raskob G; Ockelford P
    N Engl J Med; 1982 Dec; 307(27):1676-81. PubMed ID: 6755255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
    Warlow C; Terry G; Kenmure AC; Beattie AG; Ogston D; Douglas AS
    Lancet; 1973 Oct; 2(7835):934-6. PubMed ID: 4126560
    [No Abstract]   [Full Text] [Related]  

  • 27. Deep vein thrombosis. Detection and prevention.
    Kakkar VV
    Circulation; 1975 Jan; 51(1):8-19. PubMed ID: 1088937
    [No Abstract]   [Full Text] [Related]  

  • 28. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of acute deep venous thrombosis.
    Satiani B
    Am Fam Physician; 1982 Apr; 25(4):103-9. PubMed ID: 7064760
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of venous thromboembolism.
    Lancet; 1988 Feb; 1(8580):275-7. PubMed ID: 2893086
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of low-dose heparin on incidence of postoperative thrombosis in orthopaedic patients.
    Abraham-Inpijn L; Vreeken J
    Arch Chir Neerl; 1975; 27(1):63-8. PubMed ID: 1098580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous heparin. A logical prophylaxis for deep vein thrombosis after myocardial infarction.
    Marks P; Teather D
    Practitioner; 1978 Mar; 220(1317):425-7. PubMed ID: 643788
    [No Abstract]   [Full Text] [Related]  

  • 33. Current concepts of warfarin therapy.
    Peterson CE; Kwaan HC
    Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of anticoagulant oral treatment in patients with thrombus in left ventricle after acute myocardial infarction].
    Carrillo AM; Valdespino A; Solorio S; Badui E; Enciso R; Lepe L; Lara A; Ocampo S; Alonso R; Romero MA
    Arch Inst Cardiol Mex; 1997; 67(3):217-22. PubMed ID: 9412434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose heparin in the prevention of deep-vein thromboses in patients with acute myocardial infarction.
    Pitt A; Anderson ST; Habersberger PG; Rosengarten DS
    Am Heart J; 1980 May; 99(5):574-8. PubMed ID: 7369096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulant therapy: questions and answers.
    Sherry S
    Compr Ther; 1976 Dec; 2(12):58-65. PubMed ID: 1000925
    [No Abstract]   [Full Text] [Related]  

  • 38. Deep vein thrombosis and its prevention in patients with acute myocardial infarction.
    Prerovský I; Niederle P; Simonová J; Kapitola J
    Cor Vasa; 1988; 30(5):345-51. PubMed ID: 3229117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in venous thrombo-embolism. A review article.
    Sobel JD
    S Afr Med J; 1973 Jul; 47(27):1197-202. PubMed ID: 4581553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.